ID News: March/April 2017
Published by: The Public Health Agency of Canada
Issue: Volume 43-3/4: Tuberculosis (TB)
Date published: March 2, 2017
ISSN: 1481-8531
Submit a manuscript
About CCDR
Browse
Volume 43-3/4, March 2, 2017: Tuberculosis (TB)
ID News
Markers that may differentiate active from latent TB
Source: Lee JY, Jung YW, Jeong I, Joh JS, Sim SY, Choi B, Jee HG, Lim DG. Immune parameters differentiating active from laten tuberculosis infection in humans. Tuberculosis (Edinb). 2015 Dec;95(6):758-63. doi: 10.1016/j.tube.2015.08.003.
Tuberculosis remains a highly prevalent infectious disease worldwide. Identification of the immune parameters that differentiate active disease from latent infection will facilitate the development of efficient control measures as well as new diagnostic modalities for tuberculosis. Here, we investigated the cytokine production profiles of monocytes and CD4(+) T lymphocytes upon encountering mycobacterial antigens. In addition, cytokines and lipid mediators with immune-modulating activities were examined in plasma samples ex vivo. Comparison of these parameters in active tuberculosis patients and healthy subjects with latent infection revealed that, active tuberculosis was associated with diminished Th1-type cytokine secretion from CD4(+) T cells and less augmented inflammatory cytokine secretion from monocytes induced by IFN-γ than that in latent tuberculosis infection. In addition, a higher plasma concentration of lipoxin A4 and lower ratio of prostaglandin E2 to lipoxin A4 were observed in active cases than in latent infections. These findings have implications for preparing new therapeutic strategies and for differential diagnosis of the two types of tuberculosis infection.
Page details
- Date modified: